Eiger BioPharmaceuticals (EIGR) Earnings Date, Estimates & Call Transcripts

→ Nerd Investor Reveals Secret To Make Money With A.I. (From InvestorPlace) (Ad)

$1.72

-0.18 (-9.21%)

(As of 04/10/2024)

EIGR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EIGR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

Eiger BioPharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($15.62) EPS

EIGR Earnings Date and Information

Eiger BioPharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Eiger BioPharmaceuticals Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/9/2024 Estimated)	-	-	-	-	-	-	-
11/9/2023	Q3 2023	-	($12.30)	($12.30)	($0.41)	-	$3.21 million
8/14/2023	Q2 2023	-	($14.10)	($14.10)	($0.47)	-	$4.64 million
5/11/2023	Q1 2023	-	($15.60)	($15.60)	($0.52)	-	$4.12 million
3/16/2023	Q4 2022	-	($17.10)	($17.10)	($0.57)	$4.22 million	$2.70 million
11/3/2022	Q3 2022	($16.50)	($18.60)	($2.10)	($0.62)	$3.93 million	$4.02 million
8/4/2022	Q2 2022	($21.30)	($15.30)	+$6.00	($0.51)	$2.10 million	$4.09 million
Get the Latest News and Ratings for EIGR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/5/2022	Q1 2022	($19.80)	($19.20)	+$0.60	($0.64)	$3.82 million	$2.67 million
3/10/2022	Q4 2021	($20.10)	($19.20)	+$0.90	($0.64)	$2.73 million	$3.36 million
11/4/2021	Q3 2021	($17.40)	($19.50)	($2.10)	($0.65)	$2.54 million	$3.04 million
8/5/2021	Q2 2021	($16.20)	($17.10)	($0.90)	($0.57)	$1.62 million	$2.10 million
5/6/2021	Q1 2021	($15.30)	($14.70)	+$0.60	($1.83)	$0.97 million	$3.65 million

Eiger BioPharmaceuticals Earnings - Frequently Asked Questions

When is Eiger BioPharmaceuticals's earnings date?: Eiger BioPharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on EIGR's earnings history.
How much revenue does Eiger BioPharmaceuticals generate each year?: Eiger BioPharmaceuticals (NASDAQ:EIGR) has a recorded annual revenue of $15.77 million.
How much profit does Eiger BioPharmaceuticals generate each year?: Eiger BioPharmaceuticals (NASDAQ:EIGR) has a recorded net income of -$96.78 million. EIGR has generated -$59.16 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:EIGR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Eiger BioPharmaceuticals (EIGR) Earnings Date, Estimates & Call Transcripts

EIGR Earnings Estimates and Actuals by Quarter

EIGR Estimated and Actual Revenue by Quarter

Eiger BioPharmaceuticals Analyst EPS Estimates

EIGR Earnings Date and Information

Eiger BioPharmaceuticals Earnings History by Quarter

Eiger BioPharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info